✦ LIBER ✦

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells

✍ Scribed by Cécile Schiffer Mannioui,Laëtitia Lemaire…

Book ID: 126381324
Publisher: Springer (Biomed Central Ltd.)
Year: 2013
Tongue: English
Weight: 71 KB
Volume: 1
Category: Article
ISSN: 2051-1426
DOI: 10.1186/2051-1426-1-S1-P34

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CAR-modified anti-CD19 T cells for the t

CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road

✍ Gill, Saar; Porter, David L 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 465 KB

Simplified process for the production of

Simplified process for the production of anti–CD19-CAR–engineered T cells

✍ Tumaini, Barbara; Lee, Daniel W.; Lin, Tasha; Castiello, Luciano; Stroncek, Davi 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 1004 KB

Clonal CD8+ and CD52– T cells are induce

Clonal CD8+ and CD52– T cells are induced in responding B cell lymphoma patients treated with Campath-1H* (anti-CD52)

✍ A. Österborg; Å. Werner; E. Halapi; J. Lundin; U. Harmenberg; H. Wigzell; H. Mel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

Treatment of SCID/human B cell precursor

Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins

✍ Herrera, L; Yarbrough, S; Ghetie, V; Aquino, D B; Vitetta, E S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 179 KB

Bispecific CD3 × CD19 diabody for T cell

Bispecific CD3 × CD19 diabody for T cell-mediated lysis of malignant human B cells

✍ Sergey M. Kipriyanov; Gerhard Moldenhauer; Gudrun Strauss; Melvyn Little 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 315 KB

For the treatment of minimal residual disease in patients with leukemias and malignant lymphomas, we constructed a heterodimeric diabody specific for human CD19 on B cells and CD3⑀ chain of the T cell receptor complex. The bispecific diabody was expressed in Escherichia coli using a vector containin

Safety and Persistence of Infused CD19-C

Safety and Persistence of Infused CD19-Car-Modified Multivirus Specific CTLs in B Cell Malignancies Post Allogeneic Hematopoietic Stem Cell Transplantation

✍ C.R.Y. Cruz; K.P. Micklethwaite; B. Savoldo; S. Ku; R.A. Krance; O. Diouf; R. Ka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB